PECAM1 and neoplasm: Upon further assessment of tumor vascularization and neovascularization (using anti-CD31 and –αvβ3 integrin antibodies, respectively) we observed clear reduction in both features by ADI-PEG20 compared with saline control animals and maximal reduction with combined therapy (Figure 2, E and E).